NuVasive enrolled the first patients in its study comparing lateral lumbar interbody fusion outcomes with traditional smooth PEEK intervertebral spacers and two NuVasive Advanced Materials Science portfolio implants.
Here are three things to know:
1. Patients will undergo a one- or two-level XLIF procedure with smooth PEEK, Modulus 3D-printed titanium or Cohere Porous PEEK implants.
2. The study will also generate level 1 biologic outcome evidence, as each implant group will have randomization between Osteocel Pro and cancellous allograft chips with bone marrow aspirate
3. In this two-year, follow-up study, at least 10 surgeons will assess the fusion progression in approximately 300 U.S. patients.